SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
ABIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.62%79.121.1%$779.04m
AMGNAmgen Inc.
0.81%166.791.2%$478.24m
SRPTSarepta Therapeutics, Inc.
0.71%61.4127.0%$477.71m
BIIBBiogen Inc.
2.37%313.031.1%$447.74m
CELGCelgene Corporation
1.69%104.510.9%$402.67m
MDVNMedivation, Inc.
0.05%81.481.9%$381.25m
REGNRegeneron Pharmaceuticals, Inc.
-1.07%402.023.7%$314.38m
CPHDCepheid
-0.08%52.695.5%$220.42m
ALXNAlexion Pharmaceuticals, Inc.
2.07%122.542.2%$181.45m
CLVSClovis Oncology, Inc.
4.07%36.0528.4%$159.66m
ILMNIllumina, Inc.
2.89%181.663.4%$148.67m
VRTXVertex Pharmaceuticals Incorporated
2.60%87.212.3%$139.76m
INCYIncyte Corporation
2.17%94.292.8%$132.54m
TSROTESARO, Inc.
-0.34%100.2417.5%$113.57m
BMRNBioMarin Pharmaceutical Inc.
-0.28%92.524.0%$112.23m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.